Availability: Άμεσα Διαθέσιμο

Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 9th Edition 2-Volume Set

ISBN: 9780323827638
Εκδόσεις:
Διαστάσεις 28 × 22 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Συγγραφείς

, ,

Κύριος Συγγραφέας

, ,

Original price was: 410,00€.Η τρέχουσα τιμή είναι: 365,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: Υπό έκδοση

Περιγραφή

Widely considered the premier text in pediatric infectious diseases, Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 9th Edition: 2-Volume Set, provides authoritative, up-to-date coverage of this rapidly changing field. Extensively revised by Drs. James Cherry, Sheldon L. Kaplan, Gail J. Demmler-Harrison, William J. Steinbach, Peter J. Hotez, and new editor John V. Williams, this two-volume reference delivers the information you need on epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. It serves as a reliable, everyday resource for practicing ID specialists, and an invaluable reference for medical students, residents, and fellows in ID, pediatricians and internists, and others who work with neonates, children, and adolescents or in public health.
Key Features
  • Discusses infectious diseases according to organ systems that may be affected, as well as individually by microorganisms, placing emphasis on clinical manifestations that may be related to the organism causing the disease.
  • Provides detailed information regarding the best means to establish a diagnosis, explicit recommendations for therapy, and the most appropriate uses of diagnostic imaging.
  • Includes expanded information on Q fever, antibiotic resistance and antibiotic agents, human coronaviruses, pox viruses, and infections in the compromised host, and contains new COVID-19 content across numerous chapters.
  • Features a new chapter on antimicrobial stewardship, and new coverage of antivirals for pox viruses.
  • Reflects today’s more aggressive infectious and antibiotic-resistant organisms as well as emerging and re-emerging infectious diseases.
  • Contains hundreds of full-color images (many are new!), including clinical photos, radiographic images, drawings, charts, and graphs.
  • Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. Additional digital ancillary content may publish up to 6 weeks following the publication date.

Περιεχόμενα

Part 1 – Host-Parasite Relationships and the Pathogenesis of Infectious Diseases

1. Molecular Determinants of Microbial Pathogenesis

2. Normal and Impaired Immunologic Responses to Infection

3. The Host Response to Infections: The Omics Revolution

4. Fever: Pathogenesis and Treatment

5. The Human Microbiome

6. Epidemiology and Biostatistics of Infectious Diseases

Part 2 – Infection of Specific Organ Systems

Section 1 – Upper Respiratory Tract Infections

7. The Common Cold

8. Infections of the Oral Cavity

9. Pharyngitis (Pharyngitis, Tonsillitis, Tonsillopharyngitis, and Nasopharyngitis)

10. Uvulitis

11. Peritonsillar, Retropharyngeal, and Parapharyngeal Abscesses

12. Cervical Lymphadenitis

13. Parotitis

14. Rhinosinusitis

15. Otitis Externa

16. Otitis Media

17. Mastoiditis

18. Croup (Laryngitis, Laryngotracheitis, Spasmodic Croup, Laryngotracheobronchitis, Bacterial Tracheitis, and Laryngotracheobronchopneumonitis) and Epiglottitis (Supraglottitis)

Section 2 – Lower Respiratory Tract Infections

19. Acute Bronchitis

20. Chronic Bronchitis

21. Bronchiolitis and Infectious Asthma

22. Pediatric Community-Acquired Pneumonia

23. Empyema and Lung Absess

24. Children’s Interstitial Lung Disease and Hypersensitivity Pneumonitis

25. Cystic Fibrosis

Section 3 – Infections of the Heart

26. Infective Endocarditis

27. Infectious Pericarditis

28. Myocarditis

29. Acute Rheumatic Fever

30. Mediastinitis

Section 4 – Central Nervous System Infections

31. Bacterial Meningitis Beyond the Neonatal Period

32. Parameningeal Infections.

33. Fungal Meningitis

34. Eosinophilic Meningitis

35. Aseptic Meningitis and Viral Meningitis

36. Encephalitis and Meningoencephalitis

37. Parainfectious and Postinfectious Disorders of the Nervous System

37a. Parainfectious and Postinfectious Demyelinating Disorders of the Central Nervous System

37b. Infection-Associated Myelitis and Myelopathies of the Spinal Cord

37c. Guillain-Barreì Syndrome

Section 5 – Genitourinary Tract Infections

38. Urethritis

39. Cystitis and Pyelonephritis

40. Renal Abscess

41. Prostatitis

42. Genital Infections

Section 6 – Gastrointestinal Tract Infections

43. Esophagitis

44. Approach to Patients with Gastrointestinal Tract Infections and Food Poisoning

45. Clostridium Difficile Infection

46. Whipple Disease

Section 7 – Liver Diseases

47. Hepatitis

48. Cholangitis and Cholecystitis

49. Pyogenic Liver Abscess

50. Reye Syndrome

Section 8 – Other Intra-Abdominal Infections

51. Appendicitis and Pelvic Abscess

52. Pancreatitis

53. Peritonitis and Intra-Abdominal Abscess

54. Retroperitoneal Infections

Section 9 – Musculoskeletal Infections

55. Osteomyelitis

56. Septic Arthritis

57. Bacterial Myositis and Pyomyositis

Section 10 – Skin Infections

58. Cutaneous Manifestatiions of Systemic Infections

59. Roseola Infantum (Exanthem Subitum)

60. Skin Infections

60a. Bacterial Skin Infections

60b. Viral and Fungal Skin Infections

Section 11 – Ocular Infectious Diseases

61. Ocular Infections

Section 12 – Systemic Infectious Diseases

62. Bacteremia and Septic Shock

63. Fever Without Source and Fever of Unknown Origin

64. Toxic Shock Syndrome

65. Pediatric Acute Respiratory Distress Syndrome

Section 13 – Infections of the Fetus and Newborn

66. Approach to Infections in the Fetus and Newborn

Section 14 – Infections of the Compromised Host

67. Primary Immunodeficiency Diseases

68. The Febrile Neutropenic Patient

69. Opportunistic Infections in Hematopoietic Stem Cell Transplantation

70. Infections in Pediatric Heart Transplantation

71. Infections in Pediatric Lung Transplantation

72. Opportunistic Infections in Liver and Intestinal Transplantation

73. Opportunistic Infections in Kidney Transplantation

74. Infections Related to Prosthetic or Artificial Devices

75. Infections Related to Craniofacial Surgical Procedures

76. Infections in Burn Patients

Section 15 – Unclassified Infectious Diseases

77. Kawasaki Disease

78. Chronic Fatigue Syndrome

Part 3 – Infections with Specific Microorganisms

Section 16 – Bacterial Infections

79. Nomenclature for Aerobic and Anaerobic Bacteria

Subsection 1 – Gram-Positive Cocci

80. Staphylococcus aureus Infections (Coagulase-Positive Staphylococci)

81. Coagulase-Negative Staphylococcal Infections

82. Group A, Group C, and Group G Beta Hemolytic Streptococcal Infections

83. Group B Streptococcal Infections

84. Enterococcal and Viridans Streptococcal Infections

85. Pneumococcal Infections

86. Miscellaneous Gram-Positive Cocci

Subsection 2 – Gram-Negative Cocci

87. Moraxella catarrhalis

88. Meningococcal Disease

89. Gonococcal Infections

Subsection 3 – Gram-Positive Bacilli

90. Diphtheria

91. Anthrax

92. Bacillus Cereus and Other Bacillus Species

93. Arcanobacterium haemolyticum

94. Erysipelothrix rhusiopathiae

95. Listeriosis

96. Tuberculosis

97. Other Mycobacteria

98. Leprosy and Buruli Ulcer: The Major Cutaneous Mycobacterioses

99. Nocardia

100. Corynebacterium and Rhodococcus

Subsection 4 – Gram-Negative Bacilli

101. Citrobacter

102. Enterobacter

103. Extraintestinal Pathogenic Escherichia coli

104. Diarrhea-Causing and Dysentery-Causing Escherichia coli

105. Klebsiella

106. Morganella morganii

107. Proteus

108. Providencia

109. Shigella

110. Serratia

111. Salmonella

112. Plague (Yersinia pestis)

113. Other Yersinia Species.

114. Miscellaneous Enterobacteriaceae

115. Aeromonas

116. Pasteurella multocida

117. Cholera

118. Vibrio parahaemolyticus

119. Vibrio vulnificus

120. Miscellaneous Non-Enterobacteriaceae Fermentative Bacilli

121. Acinetobacter

122. Achromobacter (Alcaligenes)

123. Eikenella corrodens

124. Elizabethkingia and Chryseobacterium Species

125. Pseudomonas and Related Genera

126. Stenotrophomonas (Xanthomonas) maltophilia

Subsection 5 – Gram-Negative Coccobacilli

127. Aggregatibacter species

128. Brucellosis

129. Pertussis and Other Bordetella Infections

130. Klebsiella granulomatis

131. Campylobacter jejuni

132. Tularemia

133. Haemophilus influenzae

134. Other Haemophilus Species (Ducreyi, Haemolyticus, Influenzae Biogroup Aegyptius, Parahaemolyticus, and Parainfluenzae) and Aggregatibacter (Haemophilus) aphrophilus

135. Helicobacter pylori

136. Kingella kingae

137. Legionnaires’ Disease, Pontiac Fever, and Related Illnesses

138. Streptobacillus moniliformis (Rat-Bite Fever)

139. Bartonella Infections

Subsection 6 – Treponemataceae

140. Lyme Disease

141. Relapsing Fever

142. Leptospirosis

143. Spirillum minus (Rat-Bite Fever)

144. Syphilis

145. Nonvenereal Treponematoses

Subsection 7 – Anaerobic Bacteria

146. Clostridial Intoxication and Infection

147. Infant Botulism

148. Tetanus

149. Actinomycosis

150. Bacteroides, Fusobacterium, Prevotella, and Porphyromonas

Section 17 – Viral Infections

151. Classification and Nomenclature of Viruses

Subsection 1 (DNA) – Parvoviridae

152. Human Parvovirus B19

153. Human Bocaviruses

Subsection 2 (DNA) – Polyomaviridae

154. Human Polyomaviruses

155. Human Papillomaviruses

Subsection 3 (DNA) – Adenoviridae

156. Adenoviruses

Subsection 4 (DNA) – Hepatoviridae

157. Hepatitis B and D Viruses

Subsection 5 (DNA) – Herpesviridae

158. Herpes Simplex Viruses 1 and 2

159. Cytomegalovirus

160. Epstein-Barr Virus

161. Human Herpesviruses 6A, 6B, 7, and 8

162. Varicella-Zoster Virus

Subsection 6 (DNA) – Poxviridae

163. Smallpox (Variola Virus)

164. Monkeypox and Other Poxviruses

165. Mimiviruses

Subsection 1 (RNA) – Picornaviridae

166. Enteroviruses, Parechoviruses, and Saffold Viruses

167. Rhinoviruses

168. Hepatitis A Virus

Subsection 2 (RNA) – Caliciviridae

169. Calicivirus (Norovirus, Sapovirus, Vesivirus, Lagovirus, Nebovirus)

170. Hepatitis E Virus

Subsection 3 (RNA) – Reoviridae

171. Reoviruses

172. Orbiviruses, Coltiviruses, and Seadornaviruses

173. Rotavirus

Subsection 4 (RNA) – Togaviridae

174. Rubella Virus

175. Alphaviruses

175a. Eastern Equine Encephalitis

175b. Western Equine Encephalitis

175c. Venezuelan Equine Encephalitis

175d. Chikungunya

175e. Ross River Virus Arthritis

175f. Other Alphaviral Infections

Subsection 5 – Flaviviridae

176. Flaviviruses

176a. St. Louis Encephalitis

176b. West Nile Virus

176c. Yellow Fever

176d. Dengue, Dengue Hemorrhagic Fever, and Severe Dengue

176e. Japanese Encephalitis

176f. Murray Valley Encephalitis

176g. Tick-Borne Encephalitis

176h. Zika Virus Infections

176i. Other Flaviral Infections

177. Hepatitis C Virus

Subsection 6 – Orthomyxoviridae

178. Influenza Viruses

Subsection 7 – Paramyxoviridae

179. Parainfluenza Viruses

180. Measles Virus

181. Mumps Virus

182. Respiratory Syncytial Virus

183. Human Metapneumovirus

Subsection 8 – Rhabdoviridae

184. Rabies Virus

Subsection 9 – Arenaviridae and Filoviridae

185. Lymphocytic Choriomeningitis Virus

186. Arenaviral Hemorrhagic Fevers

187. Filoviral Hemorrhagic Fever: Marburg and Ebola Virus Fevers

Subsection 10 – Coronaviridae and Toroviridae

188. Human Coronaviruses, Including Middle East Respiratory Syndrome Coronavirus

Subsection 11 – Bunyaviridae

189. Hantaviruses.

190. La Crosse Encephalitis and Other California Serogroup Viruses

191. Other Bunyaviridae

191a. Rift Valley Fever

191b. Crimean-Congo Hemorrhagic Fever

191c. Phlebotomus Fever (Sandfly Fever)

191d. Oropouche Fever

191e. Toscana Virus

Subsection 12 – Retroviridae

192. Human Retroviruses

192a. Oncoviruses (Human T-Cell Lymphotropic Viruses) and Lentiviruses (Human Immunodeficiency Virus Type 2)

192b. Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome

Subsection 13 – Prion-Related Diseases

193. Transmissible Spongiform Encephalopathies (Creutzfeldt-Jakob Disease, Gerstmann-Sträussler-Scheinker Disease, Kuru, Fatal Familial Insomnia, New Variant Creutzfeldt-Jakob Disease, Sporadic Fatal Insomnia)

Section 18 – Chlamydia

194. Chlamydia Infections

Section 19 – Rickettsial Diseases

195. Rickettsial and Ehrlichial Diseases  .

Section 20 – Mycoplasma

196. Mycoplasma and Ureaplasma Infections

Section 21 – Fungal Diseases

197. Classification of Fungi

198. Aspergillosis

199. Blastomycosis

200. Candidiasis

201. Coccidioidomycosis

202. Paracoccidioidomycosis

203. Cryptococcosis

204. Histoplasmosis

205. Sporotrichosis

206. Mucormycosis and Entomopthoramycosis

207. Fusariosis and Scedosporiosis

208. Miscellaneous Mycoses

Section 22 – Parasitic Diseases

209. Classification and Nomenclature of Human Parasites

Subsection 1 – Protozoa

210. Amebiasis

211. Blastocystis hominis and Blastocystis spp. Infection

212. Entamoeba coli Infection

213. Giardiasis

214. Dientamoeba fragilis Infections

215. Trichomonas Infections

216. Balantidium coli Infection

217. Cryptosporidiosis

218. Cyclosporiasis, Cystoisosporiasis, and Microsporidiosis

219. Babesiosis

220. Malaria

221. Leishmaniasis

222. Trypanosomiasis

223. Naegleria, Acanthamoeba, and Balamuthia Infections

224. Toxoplasmosis

225. Pneumocystis Pneumonia

Subsection 2 – Nematodes

226. Parasitic Nematode Infections

Subsection 3 – Cestodes

227. Cestodes

Subsection 4 – Trematodes

228. Foodborne Trematodes

229. Schistosomiasis

Subsection 5 – Arthropods

230. Arthropods

Section 23 – Global Health

231. Global Health

232. International Travel Issues for Children

233. Infectious Disease Considerations in International Adoptees and Refugees

Part 4 – Therapeutics

234. Antibiotic Resistance

235. The Pharmacokinetic-Pharmacodynamic Interface: Determinants of Anti-Infective Drug Action and Efficacy in Pediatrics

236. Antibacterial Therapeutic Agents

237. Antimicrobial Prophylaxis

238. Outpatient Intravenous Antimicrobial Therapy for Serious Infections

239. Antiviral Agents

240. Antifungal Agents

241. Drugs for Parasitic Infections

242. Immunomodulating Agents

243. Probiotics

Part 5 – Prevention of Infectious Diseases

244. Health Care-Associated Infections

245. Active Immunizing Agents

246. Passive Immunization

Section 24 – Other Preventative Considerations

247. Public Health Aspects of Infectious Disease Control

248. Infections in Out-of-Home Child Care

249. Animal and Human Bites

250. Bioterrorism

Part 6 – Approach to the Laboratory Diagnosis of Infectious Diseases

251. Bacterial Laboratory Diagnosis

252. Fungal Laboratory Analysis: Specimen Collection, Direct Detection, and Culture

253. Viral Laboratory Diagnosis

254. Parasitic Laboratory Diagnosis